PSA vs SHPH · rev $4.82B vs $1.8M cap
PSA (PSA) versus Shuttle Pharmaceuticals Inc (SHPH) — a side-by-side from cached financials, not a winner call.
PSA (PSA) common stock.
Shuttle Pharmaceuticals Inc (SHPH) is a drug manufacturers - specialty & generic company listed on US.
Latest reported PSA revenue for 2025-12-31 was $4.82B. Net income was $1.78B. Revenue was up 2.7% from 2024-12-31 to 2025-12-31. PSA currently screens at market cap $0.
SHPH does not have a complete income-statement cache yet.
PSA currently screens at market cap $0. SHPH currently screens at market cap $1.8M.
Not investment advice. Open the PSA and SHPH stock pages for the full models.
Not investment advice.